aid: engrail
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/engrail.png
name: Engrail
description: 'Engrail Therapeutics is a clinical-stage biopharmaceutical company founded
  in 2019 and focused on precision neuroscience. The company develops innovative,
  precision-targeted small-molecule therapeutics aimed at the molecular mechanisms
  and neural circuits underlying nervous system disorders, combining internal discovery
  with strategic partnerships. Its pipeline includes candidates ENX-102, ENX-104,
  ENX-203, and ENX-205 for patients with devastating and life-limiting neurological
  conditions. Surfaced as a portfolio company of Norwest Venture Partners and profiled
  in the API Evangelist network; the company publishes no public developer/API surface.'
url: https://raw.githubusercontent.com/api-evangelist/engrail/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- norwest-venture-partners
x-tier: stub
x-tier-reason: identified-no-api-surface
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Pharmaceutical
- Biotechnology
- Neuroscience
- Drug Development
- Clinical Stage
- Therapeutics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/engrail-domain-security.yml
- type: Website
  url: https://engrail.com
- type: About
  url: https://www.engrail.com/about-us/
- type: TermsOfService
  url: https://www.engrail.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.engrail.com/privacy-policy/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence